NovaBay Pharmaceuticals, Inc. Consolidated Net Income/Loss

Consolidated Net Income/Loss of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Consolidated Net Income/Loss growth rates and interactive chart.


Highlights and Quick Summary

  • Consolidated Net Income/Loss for the quarter ending June 30, 2022 was $-2.16 Million (a 1841.44% increase compared to previous quarter)
  • Year-over-year quarterly Consolidated Net Income/Loss decreased by -5.85%
  • Annual Consolidated Net Income/Loss for 2021 was $-5.82 Million (a -47.19% decrease from previous year)
  • Annual Consolidated Net Income/Loss for 2020 was $-11 Million (a 14.34% increase from previous year)
  • Annual Consolidated Net Income/Loss for 2019 was $-9.65 Million (a 47.56% increase from previous year)
  • Twelve month Consolidated Net Income/Loss ending June 30, 2022 was $-4.71 Million (a 6.7% increase compared to previous quarter)
  • Twelve month trailing Consolidated Net Income/Loss decreased by -36.4% year-over-year
Trailing Consolidated Net Income/Loss for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$-4.71 Million $-4.42 Million $-5.82 Million $-7.41 Million
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Consolidated Net Income/Loss of NovaBay Pharmaceuticals, Inc.

Most recent Consolidated Net Income/Lossof NBY including historical data for past 10 years.

Interactive Chart of Consolidated Net Income/Loss of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Consolidated Net Income/Loss for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-2.16 $-0.11
2021 $-0.16 $-2.29 $-1.86 $-1.52 $-5.82
2020 $-1.74 $-3.22 $-4.48 $-1.58 $-11.03
2019 $-2.68 $-0.28 $-2.5 $-4.19 $-9.65
2018 $-1.26 $-1.54 $-1.59 $-2.15 $-6.54
2017 $0.8 $-2.45 $-1.74 $-4.01 $-7.4
2016 $-1.65 $-3.74 $-2.69 $-5.08 $-13.15
2015 $-4.22 $-5.24 $-4.88 $-4.64 $-18.97
2014 $-4.47 $-4.22 $-2.94 $-3.57 $-15.19
2013 $-4.15 $-3.84 $-4.05 $-4.01 $-16.04
2012 $-2.35 $0.08 $-2.23 $-2.53 $-7.03
2011 $-3.62 $0.11 $-5.08

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology